
Breast cancer: when should you consider genetic testing and what can it reveal?
Genetic testing can provide valuable answers when breast cancer appears repeatedly within a family or occurs unusually early. It does not predict with certainty whether someone will develop cancer. Instead, it identifies inherited genetic variants associated with increased risk, helping patients and their relatives make more informed decisions about screening, prevention and future care.
Who should consider genetic testing for breast cancer?
Discussing genetic testing for breast cancer can be particularly relevant when a personal or family history suggests that cancer may have an inherited component.
Several situations can raise the question:
- Breast cancer diagnosed at an unusually young age
- Multiple relatives affected by breast or ovarian cancer
- Male breast cancer within the family
- A known cancer-related genetic variant in a relative
- Patterns involving breast, ovarian, pancreatic or prostate cancers
Both sides of the family matter. A history of cancer on the father’s side can be just as relevant as cases involving maternal relatives. Looking at the complete family history is therefore an important part of assessing genetic risk.
At Kensington International Clinic, the Clinical Genetics service provides specialist consultations and genetic risk assessments for familial cancers, including breast cancer.
What can genetic testing actually reveal?
BRCA1 and BRCA2 are the genes most commonly associated with hereditary breast cancer, but they are not the only ones involved. Kensington International Clinic offers BRCA1 and BRCA2 screening as well as a broader breast cancer panel analysing 28 genes, including ATM, BRIP1, CHEK2 and PALB2.
Testing is performed using a blood sample and Next-Generation Sequencing, including analysis designed to identify deletions and duplications. The clinic lists a turnaround time of approximately 15 business days for its BRCA and breast cancer panels.
A result identifying a harmful inherited variant can help doctors assess risk more precisely. It may lead to personalised screening programmes, preventive strategies or targeted treatment considerations. Testing may also provide useful information for relatives who could carry the same inherited variant.
Why does specialist genetic counselling matter?
A laboratory report should never be considered in isolation. Its meaning depends on the patient’s personal history, relatives affected by cancer and the specific variant identified.
Kensington International Clinic’s Clinical Genetics service is led by Dr Ehsan Karimiani, a medical geneticist with specialist experience in counselling for familial cancers. The service includes genetic risk assessment as well as counselling before and after testing, allowing patients to understand both the test and its implications.
This guidance is particularly important because genetic testing does not always provide a simple yes-or-no answer. A negative result does not mean that someone has no risk of developing breast cancer, while identifying a variant requires careful interpretation before decisions are made.
What happens after the results?
The real value of genetic testing for breast cancer lies in what happens next. Kensington International Clinic explains that identifying inherited cancer risk can support personalised surveillance, preventive strategies, targeted treatments and testing for family members.
This turns genetic information into something practical. Depending on the result and individual circumstances, the next step may involve adapting screening or discussing preventive options with appropriate specialists.
For families in which several people have experienced cancer, the information can also help relatives understand whether further assessment is appropriate rather than living with an undefined family risk.
Could a genetics consultation give you clearer answers?
Genetic testing is most useful when it answers a well-defined clinical question. That is why starting with specialist guidance can be more valuable than simply ordering the broadest available test.
At Kensington International Clinic, patients can access specialist genetic consultations, evidence-based DNA testing, interpretation of results, preventive health strategies and family risk counselling.
When breast or related cancers repeatedly appear within a family, <a href=”kensingtoninternationalclinic.co.uk/services/genetics”>genetic testing for breast cancer</a> can replace uncertainty with a clearer understanding of inherited risk. The objective is not to predict the future with certainty, but to provide patients and their families with better information for the decisions that come next.
Leave a reply
Leave a reply